Back to results
US 2004/0167183 A1Published application
Phenethylamino sulfamic acids
AssigneeThe Procter & Gamble Company
InventorsSean Rees Klopfenstein, Matthew Brian Maier, David Robert Jones, Jeffrey Lyle Gray, Matthew Eugene Pokross, Kevin Gene Peters, Artem Gennady Evdokimov
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I): 1 are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorders such as diabetes.
Claims21
A compound according to formula (I):
- 133
- wherein:
- A) R1 is -L1-[C(R6aR6b)]mR7, wherein:
- a) L1 is selected from the group consisting of covalent bond, —O—, —S—, —N—, —CO2—, —CO—, —OCO2—, —SO—, —SO2—, —CSN(R8)—, —CON(R8)O—, —CON(R8)—, —OCON(R8)—;
- wherein R8 is hydrogen or substituted or unsubstituted C1-C5 alkyl;
- b) R6a and R6b are each independently selected from the group consisting of hydrogen, —OR9, —N(R9)2, —CO2R9, —CON(R9)2, —NHCOR9, —NHCO2R9, ═NR9, —R9, and mixtures thereof;
- wherein each R9 is independently selected from the group consisting of hydrogen, substituted or unsubstituted C1-C5 alkyl, and substituted or unsubstituted aryl or alkylenearyl;
- or two R9 units can be taken together to form a substituted or unsubstituted carbocyclic or heterocyclic ring comprising from 3 to 7 atoms;
- c) m is an index selected from 0 to 5;
- d) R7 is selected from the group consisting of nil, hydrogen, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl, substituted or unsubstituted hydrocarbyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl or alkylenearyl, substituted or unsubstituted heteroaryl or alkyleneheteroaryl;
- or
- e) R7 and a R9 can be taken together to form a substituted or unsubstituted carbocyclic or heterocyclic ring comprising from 3 to 7 atoms;
- B) R2 is —(CH2)j-L2-[C(R11aR11b)]gR12, wherein:
- a) j is an index selected from 0 to 5;
- b) L2 is selected from the group consisting of covalent bond, —O—, —S—, —N—, —CO2—, —CO—, —OCO2—, —SO—, —SO2—, —CSN(R10)—, —CON(R10)—, —CON(R10)O—, —OCON(R10)—;
- wherein R10 is hydrogen or substituted or unsubstituted C1-C5 alkyl;
- c) R11a and R11b are each independently selected from the group consisting of hydrogen, —OR13, —N(R13)2, —CO2R13, —CON(R13)2, —NHCOR13, —NHCO2R13, ═NR13, —R13, and mixtures thereof;
- wherein each R13 is independently selected from the group consisting of hydrogen, substituted or unsubstituted C1-C5 alkyl, and substituted or unsubstituted aryl or alkylenearyl;
- or two R13 units can be taken together to form a substituted or unsubstituted carbocyclic or heterocyclic ring comprising from 3 to 7 atoms;
- d) g is an index selected from 0 to 5;
- e) R12 is selected from the group consisting of nil, hydrogen, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted hydrocarbyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl or alkylenearyl, substituted or unsubstituted heteroaryl or alkyleneheteroaryl;
- or
- f) R12 and a R13 can be taken together to form a substituted or unsubstituted carbocyclic or heterocyclic ring comprising from 3 to 7 atoms;
- C) R3 is —(CH2)n-L3-R16, wherein:
- a) n is an index selected from 0 to 5;
- b) L3 is selected from covalent bond, —O—, —S—, —N—, —CO2—, —CO—, —OCO2—, —SO—, —SO2—, —CSNH—, —CONH—, —OCONH—;
- c) R16 is selected from the group consisting of hydrogen, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C1-C10 heteroalkyl substituted or unsubstituted aryl or alkylenearyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted heteroaryl or alkyleneheteroaryl;
- D) R4a, R4b, R4c and R5 are each independently selected from hydrogen or substituted unit;
- or
- E) R2 and R4a, R4a and R4b, R1 and R2, or R1 and R3 can be taken together to form a substituted or unsubstituted carbocyclic or heterocyclic ring comprising from 3 to 7 atoms.
27 more elements
Dependencies are inferred from the claim text.